Roche pushes to catch up to Novo Nordisk’s Wegovy with $3.1bn deal for obesity drugmaker Carmot

Published on 4 Dec 2023 on Fortune

The deal for three experimental medicines in obesity and diabetes could push the Swiss drugmaker...

Read the rest of the article

Start tracking your investments with Statfolio

We recently compiled a list of the 12 Best Weight Loss Stocks to Buy According to Hedge Funds. In...

Insider Monkey · via Yahoo Finance 17 Dec 2024

The Institute for Clinical and Economic Review (ICER) has identified five prescription drugs whos...

Benzinga · via Yahoo Finance 13 Dec 2024

AstraZeneca Plc (NASDAQ:AZN) and Merck & Co Inc (NYSE:MRK), on Wednesday, announced long-term...

Benzinga · via Yahoo Finance 11 Dec 2024

* Netflix: if you invested $1,000 when we doubled down in 2004, you’d have $504,097!* Right...thr...

Motley Fool · via Yahoo Finance 10 Dec 2024

We recently published a list of Jim Cramer’s Lightning Rounds: 12 Stocks Under the Spotlight. In...

Insider Monkey · via Yahoo Finance 10 Dec 2024

Astrazeneca (AZN) AstraZeneca plc, headquartered in London, UK, is one of the largest...

Zacks · via Yahoo Finance 10 Dec 2024

Year to date, Pfizer’s stock has declined 10.7%. Pfizer beat estimates in each of the last four...

Zacks · via Yahoo Finance 9 Dec 2024

For those who like to find small cap companies at attractive valuations, this free list of growin...

Simply Wall St. · via Yahoo Finance 8 Dec 2024

Some better-ranked stocks from the biotech sector are Immunocore Holdings plc IMCR, Spero...

Zacks · via Yahoo Finance 6 Dec 2024

On Thursday, the FDA approved AstraZeneca Plc's (NASDAQ:AZN) Imfinzi (durvalumab) for adult patie...

Benzinga · via Yahoo Finance 5 Dec 2024